Table 3.
Use of opioids and benzodiazepines in non-seizure patients from 2014–2016 (n=461).
| 2014 n=211 |
2015 n=135 |
P value | 2014 n=211 |
2016 n=115 |
P value | |
|---|---|---|---|---|---|---|
| Received opioid IVP [n (%)] | 69 (33%) | 56 (41%) | 0.0873 | 69 (33%) | 48 (42%) | 0.0873 |
| Received opioid IV infusion [n (%)] | 61 (29%) | 84 (42) | <0.0001 | 61 (29%) | 72 (63%) | <0.0001 |
| Received any opioid [n (%)] | 87 (41%) | 96 (71%) | <0.0001 | 87 (41%) | 75 (65%) | <0.0001 |
| Received benzodiazepine IVP [n (%)] | 120 (57%) | 41 (30%) | <0.0001 | 120 (57%) | 30 (26%) | <0.0001 |
| Received benzodiazepine infusion [n (%)] | 34 (16%) | 9 (7%) | <0.0001 | 34 (16%) | 1 (1%) | <0.0001 |
| Received any benzodiazepine [n (%)] | 127 (60%) | 43 (33%) | <0.0001 | 127 (60%) | 30 (26%) | <0.0001 |
| Received propofol [n (%)] | 68 (32%) | 36 (27%) | 0.2400 | 68 (32%) | 31 (36%) | 0.3600 |
| Received propofol only [n (%)] | 10 (5%) | 4 (3%) | 0.2800 | 10 (5%) | 9 (8%) | 0.1400 |
| No sedation [n (%)] | 42 (20%) | 23(17%) | 0.3800 | 42 (20%) | 23 (20%) | 0.1000 |
IVP, intravenous push, IV, intravenous.